| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | immunoglobulin production | 1.37e-05 | 241 | 27 | 5 | GO:0002377 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 2.08e-06 | 166 | 27 | 5 | GO:0019814 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 5.22e-07 | 194 | 23 | 6 | M16312 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 2.64e-06 | 61 | 23 | 4 | M27581 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 4.19e-06 | 154 | 23 | 5 | M39007 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 4.34e-06 | 69 | 23 | 4 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 4.34e-06 | 69 | 23 | 4 | M27150 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 4.87e-06 | 71 | 23 | 4 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 4.87e-06 | 71 | 23 | 4 | M27203 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 7.84e-06 | 80 | 23 | 4 | M6121 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 8.66e-06 | 82 | 23 | 4 | M27110 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.05e-05 | 86 | 23 | 4 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.05e-05 | 86 | 23 | 4 | M27206 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 1.10e-05 | 87 | 23 | 4 | M27205 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 1.55e-05 | 95 | 23 | 4 | M29842 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.76e-05 | 98 | 23 | 4 | M27152 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 3.30e-05 | 115 | 23 | 4 | M19752 | |
| Pathway | REACTOME_PARASITE_INFECTION | 3.42e-05 | 116 | 23 | 4 | M29843 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 6.01e-05 | 134 | 23 | 4 | M29840 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 6.36e-05 | 136 | 23 | 4 | M27207 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 7.74e-05 | 143 | 23 | 4 | M27107 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.14e-04 | 158 | 23 | 4 | MM14812 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 1.38e-04 | 166 | 23 | 4 | M608 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 2.14e-04 | 186 | 23 | 4 | M27175 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 2.32e-04 | 190 | 23 | 4 | M8240 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 3.98e-04 | 219 | 23 | 4 | M29836 | |
| Pathway | REACTOME_HEMOSTASIS | 6.09e-04 | 679 | 23 | 6 | M8395 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | 8.33e-04 | 471 | 23 | 5 | M39009 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 1.47e-03 | 35 | 23 | 2 | MM17219 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 1.72e-03 | 828 | 23 | 6 | M1058 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 1.82e-03 | 39 | 23 | 2 | MM17212 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 2.42e-03 | 45 | 23 | 2 | MM14912 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.74e-03 | 48 | 23 | 2 | MM17214 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 3.34e-03 | 53 | 23 | 2 | MM15716 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 3.46e-03 | 54 | 23 | 2 | MM14655 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 3.72e-03 | 56 | 23 | 2 | MM14815 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 3.98e-03 | 58 | 23 | 2 | MM14914 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 4.26e-03 | 60 | 23 | 2 | MM14913 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 4.26e-03 | 60 | 23 | 2 | MM14872 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 8.18e-03 | 84 | 23 | 2 | MM14653 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12833571 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 1936125 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 3100621 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15219549 | ||
| Pubmed | Amino acid sequence of the light chain variable region from a mouse anti-digoxin hybridoma antibody. | 5.80e-07 | 2 | 27 | 2 | 6404298 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 2263605 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15522311 | ||
| Pubmed | Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16. | 5.80e-07 | 2 | 27 | 2 | 2110659 | |
| Pubmed | Structural and affinity studies of IgM polyreactive natural autoantibodies. | 5.80e-07 | 2 | 27 | 2 | 8993018 | |
| Pubmed | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. | 3.19e-06 | 37 | 27 | 3 | 24162737 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 17023586 | ||
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 37166352 | ||
| Pubmed | The human immunoglobulin kappa locus. Characterization of the duplicated A regions. | 2.60e-05 | 10 | 27 | 2 | 1551402 | |
| Pubmed | 8.81e-05 | 18 | 27 | 2 | 18187417 | ||
| Pubmed | 8.81e-05 | 18 | 27 | 2 | 20399194 | ||
| Pubmed | 1.09e-04 | 20 | 27 | 2 | 10427970 | ||
| Pubmed | 1.21e-04 | 641 | 27 | 5 | 36057605 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.49e-04 | 351 | 27 | 4 | 38297188 | |
| Pubmed | 1.72e-04 | 25 | 27 | 2 | 29475039 | ||
| Pubmed | 2.01e-04 | 27 | 27 | 2 | 20564261 | ||
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 2.13e-04 | 150 | 27 | 3 | 30154076 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.41e-04 | 398 | 27 | 4 | 35016035 | |
| Pubmed | 4.67e-04 | 41 | 27 | 2 | 12076535 | ||
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | 6.67e-04 | 49 | 27 | 2 | 8951372 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 7.27e-06 | 213 | 27 | 4 | chr2p11 | |
| Cytoband | 2p12 | 4.51e-05 | 117 | 27 | 3 | 2p12 | |
| Cytoband | 6q21 | 1.47e-03 | 96 | 27 | 2 | 6q21 | |
| Cytoband | 22q11.2 | 2.28e-03 | 120 | 27 | 2 | 22q11.2 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 1.17e-04 | 83 | 21 | 3 | 351 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 4.73e-03 | 89 | 21 | 2 | 353 | |
| Coexpression | GSE27786_NKCELL_VS_NKTCELL_DN | 4.23e-05 | 199 | 26 | 4 | M4852 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 4.31e-05 | 200 | 26 | 4 | M9354 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP | 4.31e-05 | 200 | 26 | 4 | M9301 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 8.69e-05 | 87 | 26 | 3 | MM851 | |
| Coexpression | KOHN_EMT_MESENCHYMAL | 9.86e-05 | 15 | 26 | 2 | M46417 | |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN | 1.13e-04 | 16 | 26 | 2 | M41742 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2 | 1.36e-05 | 126 | 25 | 4 | Arv_SC-HD_500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3 | 2.00e-05 | 139 | 25 | 4 | Arv_SC_fibroblast_500_K3 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.86e-05 | 183 | 25 | 4 | Arv_SC_fibroblast_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.86e-05 | 183 | 25 | 4 | Arv_SC-HD_1000_K3 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.78e-04 | 244 | 25 | 4 | Arv_SC-H9hpx_1000_K4 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500 | 2.30e-04 | 489 | 25 | 5 | Arv_SC-HD_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 2.30e-04 | 489 | 25 | 5 | Arv_SC_fibroblast_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500 | 2.37e-04 | 492 | 25 | 5 | Arv_SC-H9hpx_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 2.37e-04 | 492 | 25 | 5 | Arv_SC-hpx_blastocyst_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.48e-04 | 266 | 25 | 4 | Arv_SC-hpx_blastocyst_1000_K2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.57e-04 | 129 | 25 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.60e-04 | 330 | 25 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000 | 8.17e-04 | 986 | 25 | 6 | Arv_SC-HD_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 8.17e-04 | 986 | 25 | 6 | Arv_SC_fibroblast_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000 | 8.22e-04 | 987 | 25 | 6 | Arv_SC-H9hpx_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 8.22e-04 | 987 | 25 | 6 | Arv_SC-hpx_blastocyst_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2 | 9.02e-04 | 163 | 25 | 3 | Arv_SC-hpx_blastocyst_500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3 | 1.11e-03 | 175 | 25 | 3 | Arv_SC-H9hpx_500_K3 | |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 8.79e-10 | 175 | 27 | 6 | d73ee324479172501481b54967a0f3bd870fcf3a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-08 | 173 | 27 | 5 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-08 | 178 | 27 | 5 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.91e-08 | 183 | 27 | 5 | cf5c98f451a568308c52da5c926543dd4836c6b2 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.58e-08 | 186 | 27 | 5 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 195 | 27 | 5 | df009b18898c10686f75cf72b4ec0eff18f5bb50 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-07 | 197 | 27 | 5 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-07 | 197 | 27 | 5 | 76465bb2408c7c75f694e8f7cf1a606b796afc3a | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-06 | 169 | 27 | 4 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.23e-06 | 170 | 27 | 4 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.23e-06 | 170 | 27 | 4 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.23e-06 | 170 | 27 | 4 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-06 | 171 | 27 | 4 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-06 | 171 | 27 | 4 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | COPD-Lymphoid-B_Plasma|COPD / Disease state, Lineage and Cell class | 3.79e-06 | 177 | 27 | 4 | 1b872d3b1e0fca138362098590a634d748dfca60 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-06 | 179 | 27 | 4 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-06 | 179 | 27 | 4 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.05e-06 | 180 | 27 | 4 | e3877f6ef5f54ff689058b4c996ab1851822f871 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 4.14e-06 | 181 | 27 | 4 | 949ac3b60e7fb5968da4c4e872965fb4e10f4a35 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.14e-06 | 181 | 27 | 4 | 700adfb41e4e377530f0dd31be89e12f109f3469 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 4.23e-06 | 182 | 27 | 4 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 4.32e-06 | 183 | 27 | 4 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.32e-06 | 183 | 27 | 4 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 | |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | 4.32e-06 | 183 | 27 | 4 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.41e-06 | 184 | 27 | 4 | 64bede8db709fd32f40c03265b96f0b12155bb8a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.41e-06 | 184 | 27 | 4 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.51e-06 | 185 | 27 | 4 | 609080adb2cfb105bb7b8efb617553833299f371 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-06 | 185 | 27 | 4 | 08bc817908076734d66f2805cb954141f2cc5a18 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-06 | 185 | 27 | 4 | 6ec009e48e50471c28e914c402f500e56a88f8f2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-06 | 185 | 27 | 4 | f49ad6401b2abd089e30eba245b11b5031ea2318 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-06 | 185 | 27 | 4 | 1704a12153a9b107bf03ecccd1a036cf61334d7a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-06 | 188 | 27 | 4 | 6844cebca177fdf38b21a40d606230a033717a3a | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.81e-06 | 188 | 27 | 4 | bd53b0371154cff680226897b61c9809a239d1b6 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.01e-06 | 190 | 27 | 4 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.01e-06 | 190 | 27 | 4 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 5.22e-06 | 192 | 27 | 4 | 119832d4aee29ddda2485fc3e5dcdaacf833cc30 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.33e-06 | 193 | 27 | 4 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-06 | 195 | 27 | 4 | 13f4ee21568fd747608412d33559d10561dbb3c8 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.67e-06 | 196 | 27 | 4 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.67e-06 | 196 | 27 | 4 | c38e7f533c619afe008de0e99042f7180c2da918 | |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 5.67e-06 | 196 | 27 | 4 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda | |
| ToppCell | Biopsy_Control_(H.)-Immune-Plasma_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.78e-06 | 197 | 27 | 4 | 275f38ed7e477000e864cecf9b7d49ae134c3b6a | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-06 | 199 | 27 | 4 | 8e02d3a066e79e0f2024a10738e0ea070513ef19 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.52e-05 | 142 | 27 | 3 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 1.19e-04 | 159 | 27 | 3 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-04 | 162 | 27 | 3 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-04 | 162 | 27 | 3 | f945688815229c8386cbcbf46deee7df316fa8d3 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 1.30e-04 | 164 | 27 | 3 | 3b6a32ba53d05f6818fe950ac426f489383b645a | |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma-Plasma_cells|blood / Manually curated celltypes from each tissue | 1.33e-04 | 165 | 27 | 3 | 1c0c24fe252b761cf879b83562e23c02f0b6489f | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 1.33e-04 | 165 | 27 | 3 | 1776e7db80d7cf6b449fa8635a111705a59231b4 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-04 | 167 | 27 | 3 | f2185eb72f0137136f6d71af2a70168fded6c940 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-04 | 167 | 27 | 3 | 5e768cf24699893e05d1bcb1c92dba2336943a64 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-04 | 168 | 27 | 3 | f5a18123f84c62211d9279e9c41e90122e4c4895 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 1.43e-04 | 169 | 27 | 3 | a65853ff9f6489cc1617cbba0d03b392d23c1528 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 169 | 27 | 3 | 0c2384f780ec25710ebb35c0b0df8f4afb53c9b1 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-ABC_aged-B_memory|Liver / Manually curated celltypes from each tissue | 1.48e-04 | 171 | 27 | 3 | eb47f4a09a630ed14a0898377039ed50ef7cc292 | |
| ToppCell | Control-Lymphoid-B_Plasma|Control / Disease state, Lineage and Cell class | 1.50e-04 | 172 | 27 | 3 | 61e33836b8cb0f347f3e699eb587a37073b6fa4c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 173 | 27 | 3 | 0ca2169a275404118038c0489a48062879488765 | |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.53e-04 | 173 | 27 | 3 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 1.55e-04 | 174 | 27 | 3 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | 1.61e-04 | 176 | 27 | 3 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.61e-04 | 176 | 27 | 3 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | -IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-04 | 177 | 27 | 3 | ae2d2e138946535596fa30a55207f261cafda461 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.63e-04 | 177 | 27 | 3 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.63e-04 | 177 | 27 | 3 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|tumor_Lung / Location, Cell class and cell subclass | 1.63e-04 | 177 | 27 | 3 | 37e03f51925345f5f716ef3abe1d2c4ccf129020 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-04 | 177 | 27 | 3 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-04 | 177 | 27 | 3 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-04 | 177 | 27 | 3 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 178 | 27 | 3 | 2e51c1596022b7047994ee13c18375bad19a54a5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 178 | 27 | 3 | 693f1135d9c5545945e80c7ba3d098afc0ccac29 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 178 | 27 | 3 | 34ef4d36ddfb1cdeaaaf5d952e1ad6dc2785ce1e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 178 | 27 | 3 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 178 | 27 | 3 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 180 | 27 | 3 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 180 | 27 | 3 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 181 | 27 | 3 | e7d9910f6143055645b6f03b1018282e6c215f10 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.77e-04 | 182 | 27 | 3 | 27d1688fdfc570cedd233aa7030bce7d9b604d42 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-04 | 182 | 27 | 3 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 1.77e-04 | 182 | 27 | 3 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.80e-04 | 183 | 27 | 3 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-04 | 184 | 27 | 3 | 15f2c10101ccc8ed059520fc082ee42593dff269 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-04 | 184 | 27 | 3 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 185 | 27 | 3 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 185 | 27 | 3 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.89e-04 | 186 | 27 | 3 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 | |
| ToppCell | mild-Lymphocytic-Plasmablast|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.89e-04 | 186 | 27 | 3 | 060510c21b1e0889b7a6eeb15821b9e2f03a0f99 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-04 | 187 | 27 | 3 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 191 | 27 | 3 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.04e-04 | 191 | 27 | 3 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 192 | 27 | 3 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-04 | 193 | 27 | 3 | e9bbc2c4516341524686aa095aae4ae7e80a688a | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.11e-04 | 193 | 27 | 3 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 193 | 27 | 3 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.11e-04 | 193 | 27 | 3 | 5c5543e7c83ecea44d23521246592c0301044173 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-04 | 194 | 27 | 3 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 2.14e-04 | 194 | 27 | 3 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-04 | 194 | 27 | 3 | 4a4cc61193344bb151439f63d0584abddde47cf0 | |
| ToppCell | Biopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.17e-04 | 195 | 27 | 3 | d0305c6a68c9e361507b04db94f86873085d49b3 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-04 | 197 | 27 | 3 | 88b29d205237f07a9a26cc15a1cf4ed4816a4c4b | |
| Drug | Apigenin [520-36-5]; Up 200; 14.8uM; HL60; HT_HG-U133A | 2.85e-05 | 178 | 23 | 4 | 1321_UP | |
| Drug | Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; PC3; HT_HG-U133A | 4.15e-05 | 196 | 23 | 4 | 7271_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; HL60; HT_HG-U133A | 4.32e-05 | 198 | 23 | 4 | 1272_UP | |
| Drug | L-640,035 | 1.32e-04 | 17 | 23 | 2 | CID000127538 | |
| Drug | dibenamine | 3.13e-04 | 26 | 23 | 2 | CID000005820 | |
| Drug | OOHL | 3.90e-04 | 29 | 23 | 2 | CID000127293 | |
| Drug | Ethacrynic acid [58-54-8]; Down 200; 13.2uM; HL60; HG-U133A | 8.16e-04 | 184 | 23 | 3 | 1565_DN | |
| Drug | tripelennamine | 8.20e-04 | 42 | 23 | 2 | CID000005587 | |
| Drug | methoxyl | 9.00e-04 | 44 | 23 | 2 | CID000123146 | |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2479_DN | |
| Drug | Triflusal [322-79-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 2867_UP | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; HL60; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 1330_UP | |
| Disease | Sezary Syndrome | 2.39e-04 | 27 | 25 | 2 | C0036920 | |
| Disease | Alzheimer disease | 6.93e-04 | 485 | 25 | 4 | MONDO_0004975 | |
| Disease | pulse pressure measurement | 8.90e-04 | 1392 | 25 | 6 | EFO_0005763 | |
| Disease | keratoconus | 1.43e-03 | 66 | 25 | 2 | MONDO_0015486 | |
| Disease | late-onset Alzheimers disease | 1.88e-03 | 292 | 25 | 3 | EFO_1001870 | |
| Disease | sugar consumption measurement | 4.63e-03 | 120 | 25 | 2 | EFO_0010158 | |
| Disease | corneal resistance factor | 6.35e-03 | 451 | 25 | 3 | EFO_0010067 | |
| Disease | intraocular pressure measurement | 8.85e-03 | 509 | 25 | 3 | EFO_0004695 | |
| Disease | Leukemia, Myelocytic, Acute | 9.38e-03 | 173 | 25 | 2 | C0023467 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGKLLQPKYLQPLLA | 246 | P05026 | |
| NTLGPQYLALYLQLL | 221 | Q92879 | |
| LLPQQSYSLAQPLYS | 221 | Q6W2J9 | |
| TSLLAKLYIPLPNYT | 556 | Q6DHV5 | |
| QPSYYLSTNLPLTQK | 1276 | P59510 | |
| LQKKNLFPYNPTALL | 726 | Q8NG48 | |
| YLQKPGQSPQLLIYL | 61 | P01615 | |
| KFLNLPPRISQYNLY | 271 | Q8IZT8 | |
| YQQLPGTAPKLLIYS | 56 | P01700 | |
| PSLQQKNTLLPLYLY | 311 | Q330K2 | |
| YQQLPGTAPKLLIYS | 56 | P01699 | |
| SYLQSLLLFPPQQLK | 661 | Q16891 | |
| INPLLNPLIYSLRNK | 296 | Q8NGQ1 | |
| SQLPLPRSLHNYLLY | 486 | Q9Y575 | |
| YLQKPGQSPQLLIYL | 61 | A0A075B6P5 | |
| YLQKPGQSPQLLIYE | 61 | A2NJV5 | |
| LLAGYLAQQYLPLPT | 16 | P48723 | |
| LGYINSTLNPLIYPL | 456 | P35367 | |
| PILQSILPLLNIYYL | 71 | Q15345 | |
| QLLYLQEESTPYKPQ | 3796 | Q9P2P6 | |
| RNYLPILNSYTKIAP | 151 | Q9C0C6 | |
| FRLYQLLNLHYPPKL | 236 | O00541 | |
| NATYYITKQILPPLA | 2981 | O60673 | |
| QPPLKNLLSLLKAYY | 586 | P37275 | |
| FLLLTTNNPAIYKLP | 871 | Q15849 | |
| NLYLKLPKPYITINN | 141 | Q15238 | |
| YYSQLLTKNNLSNPP | 4606 | O14686 |